EMA Highlights: New guideline on Alzheimer’s medicines
by Gary Finnegan: The European Medicines Agency has released a revised guideline on medicines for the treatment of Alzheimer’s disease and other forms of dementia. The publication is… read more.
by Gary Finnegan: The European Medicines Agency has released a revised guideline on medicines for the treatment of Alzheimer’s disease and other forms of dementia. The publication is… read more.
by Gary Finnegan: The European Medicines Agency has set up a task force on Zika virus in an effort to accelerate the development of new medicines and vaccines… read more.
by Thomas R. Collins: Standing at the center of a decade and a half of stunning advancements in the treatment of multiple myeloma is the ubiquitin proteasome pathway… read more.
by Bruce Sylvester: Women with heart failure are as likely as men to achieve survival benefit from receiving an implantable cardiac defibrillator, researchers reported on Jan. 12,2016 in Circulation: Heart… read more.
by Thomas R. Collins: Fresh off its approval in the U.S. in the relapsed/refractory setting of multiple myeloma, ixazomib continues to be examined in other patient pools, with… read more.
by Bruce Sylvester: No matter what their blood pressure is at the beginning of treatment, blood pressure-lowering drugs should be offered to all persons at high risk of… read more.
by Gary Finnegan: Ten medicines, including a first-in-class orphan medicine for narcolepsy, were recommended for authorisation in the EU at the latest meeting of the European Medicines Agency’s Committee for Medicinal… read more.
by Gary Finnegan: The European Medicines Agency (EMA) says its powers are limited when it comes to regulating off-label use of licensed medicines. The watchdog is at the… read more.
by Gary Finnegan: Black women in Canada have substantially higher risk of preterm birth than white women, according to a new study which mirrors disparities previously reported in… read more.
by Gary Finnegan: Researchers in Denmark have found a small but significant increase in the risk of developing epilepsy among children who had hospital-diagnosed pertussis infections. While the… read more.
by Bruce Sylvester: Thrombus aspiration preceding percutaneous coronary intervention (PCI) failed to improve one-year clinical outcomes in patients with non-ST-elevation myocardial infarction (NSTEMI), researchers from the TATORT-NSTEMI trial… read more.
by Maria Dalby: Managing patients with active disease who fail to respond to anti-TNF therapy remains a key unmet need in IBD. Introducing a free paper session on… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.